Nalaganje...
Hemorrhagic pericarditis associated with rivaroxaban in an atrial fibrillation patient with pacemaker
Rivaroxaban is a new oral anticoagulant used for the prevention of stroke in patients with atrial fibrillation. Hemorrhagic pericarditis is known to occur with rivaroxaban; however, only a few case reports in the literature describe such events. Recently, we experienced hemorrhagic pericarditis that...
Shranjeno v:
| izdano v: | Transl Clin Pharmacol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Korean Society for Clinical Pharmacology and Therapeutics
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7033380/ https://ncbi.nlm.nih.gov/pubmed/32095464 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12793/tcp.2017.25.3.138 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|